+1-858-251-2010 info@nucleusbiologics.com
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
0 Items
Nucleus Biologics
  • Home
  • Products
    • Physiologix™ XF SR
    • Vitronectin XF™
    • Media and Buffers
    • NB-ROC™ SF
    • CMRL Media
  • Formulation Services
  • Quality
  • NB-Lux
  • NB-AIR
  • Krakatoa™
  • Education
    • Education
    • Technical Documentation
  • Our Purpose
    • Serving Science
    • Curing Disease
    • Leadership Team
    • Board of Directors
  • FAQ
  • Contact
    • Contact Us
    • Careers
Select Page
Development of a Cell Therapy to Restore Vision aided by Vitronectin XF™

Development of a Cell Therapy to Restore Vision aided by Vitronectin XF™

by Brad N. Taylor, Ph.D. | Feb 8, 2022

Age-related macular degeneration (AMD) is the degeneration/dysregulation of cells of the retinal pigment epithelium (RPE) and is the most common cause of severe loss of central vision among people 50 and older, affecting approximately 200 million people worldwide [1]....
Defining the Undefined with Vitronectin XF™ – Part 3

Defining the Undefined with Vitronectin XF™ – Part 3

by Brad N. Taylor, Ph.D. | Jan 18, 2022

Getting Attached In the final part of this 3-part blog series, Defining the undefined with Vitronectin XF™, get attached to Vitronectin even more as we delve into the performance data. In our previous blogs, we discussed how mixed extracellular matrix (ECM) gels such...
Defining the Undefined with Vitronectin XF™ – Part 2

Defining the Undefined with Vitronectin XF™ – Part 2

by Brad N. Taylor, Ph.D. | Jan 11, 2022

Clearing the Regulatory Hurdles Defined single component ECM gels have distinct advantages for stem cell therapies, improving patient safety and accelerating regulatory approval. Last week, we looked at the evolution in cell culture for mesenchymal (MSC) and induced...
Defining the Undefined with Vitronectin XF™ – Part 1

Defining the Undefined with Vitronectin XF™ – Part 1

by Brad N. Taylor, Ph.D. | Jan 4, 2022

Bringing Standardization to Stem Cell Process Development. A recombinant cell attachment factor brings standardization to stem cell production. Over the last few decades, human embryonic stem cells (hESCs) and subsequently induced pluripotent stem cells (iPSCs) have...
Intelligent Media Design to Drive Better Therapeutic Outcomes

Intelligent Media Design to Drive Better Therapeutic Outcomes

by Brad N. Taylor, Ph.D. | Jun 14, 2021

Our mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. We deliver innovative, transparent, and cGMP products and services with the goal of disrupting the market and eliminating...
« Older Entries

Search

Tags

cell culture media Cell Therapy cgmp Concierge gmp IPSCs Islet cells iso Krakatoa Media Manufacturing MSCs NB-AIR NB-ROC NB Lux physiologix Press Release Reproducibility scale-up Stem Cells sustainability T Cell Vitronectin webinar XF
  • NB-Lux
  • NB-AIR
  • Krakatoa™
  • Products
  • Education
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • LinkedIn
  • Facebook
  • Twitter
©2022 Nucleus Biologics, LLC. All Rights Reserved.